An experimental trial of recombinant human interferon alpha nasal drops to prevent COVID-19 in medical staff in an epidemic area

Zhongji Meng, Tongyu Wang, Li Chen, Xinhe Chen, Longti Li, Xueqin Qin, Hai Li, Jie Luo
doi: https://doi.org/10.1101/2020.04.11.20061473

Article usage

Article usage: April 2020 to October 2024

AbstractFullPdf
Apr 20201542904680
May 2020640902947
Jun 202016630552
Jul 2020671201053
Aug 202025540572
Sep 202013260314
Oct 202019250345
Nov 202015230263
Dec 2020118235169
Jan 2021119340158
Feb 20218771995
Mar 20211070335116
Apr 20219614085
May 202161835101
Jun 202147091106
Jul 20215234181
Aug 20216354887
Sep 20216052374
Oct 202138813110
Nov 20217282297
Dec 202171520123
Jan 20227778366
Feb 20222731860
Mar 2022170943
Apr 20221923764
May 20221401764
Jun 20221491528
Jul 20222343134
Aug 20221541439
Sep 2022155735
Oct 2022160351
Nov 20223371341
Dec 20221571238
Jan 2023106744
Feb 20231051339
Mar 202399433
Apr 202371344
May 202347540
Jun 202356426
Jul 202354722
Aug 2023591938
Sep 20231071335
Oct 20232551130
Nov 20234271919
Dec 2023531826
Jan 202442618
Feb 2024381329
Mar 2024391426
Apr 2024481139
May 202457824
Jun 202435822
Jul 202462927
Aug 2024541234
Sep 2024741136
Oct 202452521
Back to top
Posted May 07, 2020.
Download PDF
Data/Code
Email
An experimental trial of recombinant human interferon alpha nasal drops to prevent COVID-19 in medical staff in an epidemic area
Zhongji Meng, Tongyu Wang, Li Chen, Xinhe Chen, Longti Li, Xueqin Qin, Hai Li, Jie Luo
medRxiv 2020.04.11.20061473; doi: https://doi.org/10.1101/2020.04.11.20061473
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area